Paul Parkinson is EVP Strategy and Innovation of MYRIAD GENETICS INC. Currently has a direct ownership of 87,407 shares of MYGN, which is worth approximately $1.18 Million. The most recent transaction as insider was on Mar 24, 2021, when has been sold 10,661 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.4K
0% 3M change
0% 12M change
Total Value Held $1.18 Million

Paul Parkinson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2021
BUY
Grant, award, or other acquisition
-
10,661 Added 10.87%
87,407 Common Stock
Jan 08 2021
SELL
Open market or private sale
$295,600 $25.0 p/Share
11,824 Reduced 13.35%
76,746 Common Stock
Oct 31 2020
SELL
Sale (or disposition) back to the issuer
$27,570 $12.43 p/Share
2,218 Reduced 2.44%
88,570 Common Stock
Oct 08 2020
BUY
Grant, award, or other acquisition
-
21,730 Added 19.31%
90,788 Common Stock
PP

Paul Parkinson

EVP Strategy and Innovation
Salt Lake City, UT

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN